Your session is about to expire
← Back to Search
High Dose THC Marijuana for Cannabis Impairment
Study Summary
This trial will study how marijuana affects cognition and simulated driving over time.
- Cannabis Impairment
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 4 trial • 46 Patients • NCT03008005Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
To what extent is this experimental research being conducted with human participants?
"Currently, this clinical trial is not accepting participants. It was originally posted in December 2017 and most recently updated on January 24th 2022. If you are seeking other medical studies related to marijuana use disorder or High Dose THC Marijuana, there are 117 and 31 trials respectively that require enrolment at the moment."
For which individuals is enrollment in this trial permissible?
"To qualify for enrollment in this marijuana abuse trial, applicants must be between 20 and 40 years of age. Approximately 27 participants will ultimately join the study."
Is this experimentation unprecedented in its field?
"Since its inaugural study in 2015, sponsored by Jazz Pharmaceuticals, research regarding High Dose THC Marijuana has been conducted extensively. This culminated in the drug receiving Phase 2 & 3 approval for clinical use after a 200-person trial. Currently, 31 live studies are being held across 32 cities and 5 nations internationally."
What other experiments involving high doses of THC cannabis have been conducted?
"Currently, 31 clinical trials pertaining to High Dose THC Marijuana are ongoing with 3 of them in the late-stage Phase 3. While Hartford, Connecticut serves as a hub for research related to this compound, there is participation from 46 medical centres across the world."
What are the ambitions of this medical trial?
"This clinical trial's primary evaluation metric is the alteration of performance on Cogstate Social/Emotional Cognition task when given Marijuana; this will be measured over a time frame of 10 minutes to 6.5 hours post-administration. Secondary objectives are the determination of changes in operational control (measured via standard deviation of lane position), concentration levels for THC and its metabolites in blood samples, as well as oral fluid tested using Quantisal Oral Fluid Collection devices."
Is this research study still open to participants?
"As indicated by clinicaltrials.gov, this particular research project is no longer actively recruiting patients: it was initially posted in December 2017 and the last update occurred on January 24th 2022. Nonetheless, there are currently 148 other clinical trials seeking new participants."
Does the eligibility criteria for this trial extend to those above 30 years of age?
"This research is seeking individuals between the ages of 20 and 40 to participate."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger